Hjem › Leukemi › New York › New York City
Kliniske studier for Leukemi i New York City, NY
19 studier for Leukemi søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
RekruttererFase 1/2
- Montefiore Medical Center, New York
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
RekruttererFase 2
- Weill Cornell, New York
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center, New York
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekruttererFase 2
- Columbia University Medical Center New York Presbyterian, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RekruttererFase 3
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
- Weill Cornell Medical Center, New York
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College-NY Presbyterian Hospital, New York
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
RekruttererFase 1/2
- Research Site, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RekruttererFase 2
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
CD4CAR for CD4+ Leukemia and Lymphoma
RekruttererFase 1
- Albert Einstein Health Network, New York
A Study of Revumenib and Mezigdomide in People With Leukemia
RekruttererFase 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
RekruttererFase 1/2
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RekruttererFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
RekruttererFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekruttererFase 2/3
- Perlmutter Cancer Center - 34th Street, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RekruttererFase 1
- New York - Presbyterian / Weill Cornell Medicine, New York
- Mount Sinai - Ruttenberg Treatment Center, New York
- Columbia University Medical Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, New York
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
RekruttererFase 1
- Memorial Sloan Kettering Cancer Center, New York
Leukemi-studier i andre byer
- Houston, TX28 studier
- Boston, MA25 studier
- Los Angeles, CA16 studier
- Chicago, IL16 studier
- Durham, NC13 studier
- Philadelphia, PA12 studier
- Columbus, OH12 studier
- Nashville, TN12 studier
- Baldwin Park, CA12 studier
- Milwaukee, WI11 studier
- Seattle, WA11 studier
- Atlanta, GA11 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.